{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "European Pharmaceutical Review"}, "author": null, "title": "Antibody-immunotherapy combination shows promise in lung cancer - European Pharmaceutical Review", "description": "Combining a PD1 inhibitor with dupilumab enabled certain patients to gain near-complete clinical response two months post-dose, research says.", "url": "https://www.europeanpharmaceuticalreview.com/news/189790/antibody-immunotherapy-combination-shows-promise-in-lung-cancer/", "urlToImage": "https://www.europeanpharmaceuticalreview.com/wp-content/uploads/lung-cancer-immunotherapy.jpg", "publishedAt": "2023-12-06T17:04:49Z", "content": "Posted: 6 December 2023 | Catherine Eckford (European Pharmaceutical Review) | No comments yet\r\nA study evaluating the combination of a PD1 inhibitor with dupilumab enabled one out of six lung cancer\u2026 [+3302 chars]"}]}